<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37368057</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Occurrence and localization of FOXP3&#x2009;+&#x2009;cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis.</ArticleTitle><Pagination><StartPage>2889</StartPage><EndPage>2895</EndPage><MedlinePgn>2889-2895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06676-8</ELocationID><Abstract><AbstractText>The study aims to increase the understanding regarding the role of regulatory T cells (Tregs) in lupus nephritis (LN) and ANCA-associated vasculitis (AAV) by comparing their localization in renal tissue and changes following immunosuppressive therapy. Kidney biopsies from 12 patients with LN and 7 patients with AAV were examined. Kidney biopsies had been performed both at active disease and following immunosuppressive treatment. Clinical data was collected at both biopsy occasions. Expression of Forkhead Box P 3 (Foxp3) in renal tissue was assessed by immunohistochemistry. An arbitrary scale was used to estimate the number of Foxp3+ cells. In LN, 8/12 (67%) had positive tissue staining for Foxp3 at baseline, most pronounced in inflammatory infiltrates, but also interstitially and in a peri-glomerular pattern. At second biopsies, after immunosuppressive treatment, 4/12 (33%) still had detectable Foxp3+ cells, found in persisting inflammatory infiltrates and some in the interstitium. Patients with a good clinical response to treatment had high grade of Foxp3+ cells in first biopsies. In AAV, only 2/7 (29%) had positive staining for Foxp3 at baseline, in inflammatory infiltrates and to a lesser extent in the interstitium, despite large areas of inflammatory infiltrates in all patients. At follow-up, 2/7 (29%) biopsies were positive for Foxp3. Our data show a higher presence of Foxp3+ cells in renal tissue from LN patients compared to AAV, suggesting that Tregs may be differently involved in the control of inflammatory mechanisms in these diseases. These findings could have further implication for therapeutic approaches aiming at restoring the immunological tolerance. Key Points &#x2022; Foxp3+-cells are present in larger amount in renal tissue in lupus nephritis vs. ANCA-associated vasculitis. &#x2022; Our data suggest that Foxp3+ regulatory T cells are involved in the control of inflammatory processes in lupus nephritis.</AbstractText><CopyrightInformation>&#xa9; 2023. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zickert</LastName><ForeName>Agneta</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9843-3127</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Rheumatology Unit, Karolinska Institutet, Solna, Sweden. agneta.zickert@regionstockholm.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Unit, S-171 76, Karolinska University Hospital, Stockholm, Sweden. agneta.zickert@regionstockholm.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankovi&#x107;</LastName><ForeName>Marija Ratkovi&#x107;</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Clinic of Pediatrics, University Clinical Center Nis, Medical Faculty, University of Nis, Nis, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malmstr&#xf6;m</LastName><ForeName>Vivianne</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rheumatology Unit, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chemin</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rheumatology Unit, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnarsson</LastName><ForeName>Iva</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rheumatology Unit, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Unit, S-171 76, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C418974">FOXP3 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007678" MajorTopicYN="N">Kidney Glomerulus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056648" MajorTopicYN="Y">Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANCA-associated vasculitis</Keyword><Keyword MajorTopicYN="N">FOXP3&#x2009;+&#x2009;cells</Keyword><Keyword MajorTopicYN="N">Kidney biopsies</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37368057</ArticleId><ArticleId IdType="pmc">PMC10497686</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06676-8</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06676-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singh S, Saxena R. Lupus nephritis. Am J Med Sci. 2009;337(6):451&#x2013;60. doi: 10.1097/MAJ.0b013e3181907b3d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e3181907b3d</ArticleId><ArticleId IdType="pubmed">19390431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizui M, Tsokos GC. Targeting regulatory T cells to treat patients with systemic lupus erythematosus. Front Immunol. 2018;9:786. doi: 10.3389/fimmu.2018.00786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00786</ArticleId><ArticleId IdType="pmc">PMC5932391</ArticleId><ArticleId IdType="pubmed">29755456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Olsen N, Zheng SG. The progress and prospect of regulatory T cells in autoimmune diseases. J Autoimmun. 2020;111:102461. doi: 10.1016/j.jaut.2020.102461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102461</ArticleId><ArticleId IdType="pubmed">32305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68&#x2013;73. doi: 10.1038/83784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/83784</ArticleId><ArticleId IdType="pubmed">11138001</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs S, Scheffschick A, Gunnarsson I, Brauner H. Natural killer cells in anti-neutrophil cytoplasmic antibody-associated vasculitis &#x2014; a review of the literature. Front Immunol. 2021;12:796640. doi: 10.3389/fimmu.2021.796640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.796640</ArticleId><ArticleId IdType="pmc">PMC8805084</ArticleId><ArticleId IdType="pubmed">35116030</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda V, Moroni G, Messa P. ANCA-associated vasculitis with renal involvement. J Nephrol. 2018;31(2):197&#x2013;208. doi: 10.1007/s40620-017-0412-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-017-0412-z</ArticleId><ArticleId IdType="pubmed">28560688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronbichler A, Lee KH, Denicolo S, Choi D, Lee H, Ahn D et al (2020) Immunopathogenesis of ANCA-associated vasculitis. Int J Mol Sci 21(19):7319</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584042</ArticleId><ArticleId IdType="pubmed">33023023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271&#x2013;7. doi: 10.1002/art.1780251101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;86. doi: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771&#x2013;82. doi: 10.1136/annrheumdis-2012-201940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-201940</ArticleId><ArticleId IdType="pmc">PMC3465859</ArticleId><ArticleId IdType="pubmed">22851469</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D&#x2019;Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241&#x2013;50. doi: 10.1097/01.ASN.0000108969.21691.5D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000108969.21691.5D</ArticleId><ArticleId IdType="pubmed">14747370</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin HA, 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pubmed">6351607</ArticleId></ArticleIdList></Reference><Reference><Citation>Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628&#x2013;1636. doi: 10.1681/ASN.2010050477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010050477</ArticleId><ArticleId IdType="pubmed">20616173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zickert A, Lannfelt K, Schmidt Mende J, Sundelin B, Gunnarsson I. Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment. Rheumatology (Oxford) 2021;60(7):3443&#x2013;3450. doi: 10.1093/rheumatology/keaa788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa788</ArticleId><ArticleId IdType="pubmed">33367774</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakweer MM, Behairy M, Elhefnawy NG, Elsaid TW. Value of Foxp3 expressing T-regulatory cells in renal tissue in lupus nephritis; an immunohistochemical study. J Nephropathol. 2016;5(3):105&#x2013;10. doi: 10.15171/jnp.2016.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/jnp.2016.19</ArticleId><ArticleId IdType="pmc">PMC4961819</ArticleId><ArticleId IdType="pubmed">27540538</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayed A, Mohamed A, Ahmed RA, Abouzeid S, Soliman A, Fathy A. Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus. Lupus. 2021;8:9612033211030559.</Citation><ArticleIdList><ArticleId IdType="pubmed">34238088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Gabr H, Anwar S, Bastawy S, Salah L. The relation of CD4(+)CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus. Lupus. 2022;31(4):463&#x2013;471. doi: 10.1177/09612033221083269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221083269</ArticleId><ArticleId IdType="pubmed">35249399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45(2):344&#x2013;355. doi: 10.1002/eji.201344280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201344280</ArticleId><ArticleId IdType="pubmed">25378177</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Zhang R, Shao M, Zhao X, Miao M, Chen J et al (2020) Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 79(1):141&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937406</ArticleId><ArticleId IdType="pubmed">31537547</ArticleId></ArticleIdList></Reference><Reference><Citation>Humrich JY, Cacoub P, Rosenzwajg M, Pitoiset F, Pham HP, Guidoux J, et al. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial. Ann Rheum Dis. 2022;81(12):1685&#x2013;1694. doi: 10.1136/ard-2022-222501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-222501</ArticleId><ArticleId IdType="pubmed">35973803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>